These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 12679408)
41. Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review. Cumming P Synapse; 2011 Sep; 65(9):892-909. PubMed ID: 21308799 [TBL] [Abstract][Full Text] [Related]
42. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique. Sasaki T; Ishiwata K; Murata T; Senda M Synapse; 2002 Apr; 44(1):42-50. PubMed ID: 11842445 [TBL] [Abstract][Full Text] [Related]
43. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5. Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Mukherjee J; Yang ZY; Lew R; Brown T; Kronmal S; Cooper MD; Seiden LS Synapse; 1997 Sep; 27(1):1-13. PubMed ID: 9268060 [TBL] [Abstract][Full Text] [Related]
45. Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates. Moerlein SM; Perlmutter JS; Cutler PD; Welch MJ Nucl Med Biol; 1997 May; 24(4):311-8. PubMed ID: 9257329 [TBL] [Abstract][Full Text] [Related]
46. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. Tipre DN; Zoghbi SS; Liow JS; Green MV; Seidel J; Ichise M; Innis RB; Pike VW J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642 [TBL] [Abstract][Full Text] [Related]
47. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images. Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483 [TBL] [Abstract][Full Text] [Related]
48. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Skinbjerg M; Liow JS; Seneca N; Hong J; Lu S; Thorsell A; Heilig M; Pike VW; Halldin C; Sibley DR; Innis RB Neuroimage; 2010 May; 50(4):1402-7. PubMed ID: 20097293 [TBL] [Abstract][Full Text] [Related]
49. Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methods. Syvänen S; de Lange EC; Tagawa Y; Schenke M; Molthoff CF; Windhorst AD; Lammertsma AA; Voskuyl RA Neuroimage; 2011 Aug; 57(3):928-37. PubMed ID: 21609773 [TBL] [Abstract][Full Text] [Related]
50. (+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET. Kassiou M; Loc'h C; Bottlaender M; Mardon K; Ottaviani M; Coulon C; Katsifis A; Maziere B Nucl Med Biol; 2002 Apr; 29(3):295-302. PubMed ID: 11929698 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma(1) receptors. Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Kida T; Obayashi S; Suzuki K; Suhara T Nucl Med Biol; 2002 May; 29(4):469-76. PubMed ID: 12031882 [TBL] [Abstract][Full Text] [Related]
52. PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease. Rinne JO; Laihinen A; Någren K; Bergman J; Solin O; Haaparanta M; Ruotsalainen U; Rinne UK J Neurosci Res; 1990 Dec; 27(4):494-9. PubMed ID: 1981915 [TBL] [Abstract][Full Text] [Related]
53. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain. Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911 [TBL] [Abstract][Full Text] [Related]
54. In vivo comparative imaging of dopamine D2 knockout and wild-type mice with (11)C-raclopride and microPET. Thanos PK; Taintor NB; Alexoff D; Vaska P; Logan J; Grandy DK; Fang Y; Lee JH; Fowler JS; Volkow ND; Rubinstein M J Nucl Med; 2002 Nov; 43(11):1570-7. PubMed ID: 12411561 [TBL] [Abstract][Full Text] [Related]
55. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system. Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499 [TBL] [Abstract][Full Text] [Related]
56. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. Olsson H; Halldin C; Swahn CG; Farde L J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641 [TBL] [Abstract][Full Text] [Related]
57. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972 [TBL] [Abstract][Full Text] [Related]
58. Determination of dopamine D(4) receptor density in rat striatum using PB12 as a probe. Colabufo NA; Berardi F; Calò R; Leopoldo M; Perrone R; Tortorella V Eur J Pharmacol; 2001 Sep; 427(1):1-5. PubMed ID: 11553357 [TBL] [Abstract][Full Text] [Related]
59. Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data. Mauger G; Saba W; Hantraye P; Dolle F; Coulon C; Bramoullé Y; Chalon S; Grégoire MC J Cereb Blood Flow Metab; 2005 Nov; 25(11):1517-27. PubMed ID: 15917750 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of 18F-FA-4 and 11C-pipzA-4 as radioligands for the in vivo evaluation of the high-affinity choline uptake system. Gilissen C; de Groot TJ; Bronfman F; van Leuven F; Verbruggen AM; Bormans GM J Nucl Med; 2003 Feb; 44(2):269-75. PubMed ID: 12571220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]